The pharmacokinetics and effects of prochlorperazine in elderly female volunteers.

Author: BatemanD N, IsahA O, RawlinsM D

Paper Details 
Original Abstract of the Article :
The pharmacokinetics and effects of prochlorperazine (PCZ) have been studied in six healthy elderly female volunteers in a double-blind placebo-controlled study of 3.125 mg intravenous (IV) and 25 mg oral PCZ. The pharmacokinetics of IV PCZ in elderly subjects appear similar to those previously obta...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1093/ageing/21.1.27

データ提供:米国国立医学図書館(NLM)

Prochlorperazine in the Elderly: Exploring Pharmacokinetics and Effects

Prochlorperazine, a medication commonly used to treat nausea and vomiting, can have different effects in different populations. This research investigates the pharmacokinetics and effects of prochlorperazine in elderly female volunteers, aiming to understand potential age-related differences in drug response.

A Journey Through Time: Exploring Age-Related Differences in Pharmacokinetics

The authors conducted a double-blind placebo-controlled study involving six healthy elderly female volunteers. They found that the pharmacokinetics of intravenous prochlorperazine in elderly subjects appeared similar to those observed in younger subjects. However, they noted that oral bioavailability was significantly lower in the elderly, suggesting that age-related changes in drug absorption might occur. This finding emphasizes the importance of considering age-related factors when prescribing prochlorperazine.

A Shifting Landscape: Understanding Age-Related Differences in Drug Effects

The researchers also explored the pharmacological actions of prochlorperazine in the elderly, finding evidence of antidopaminergic and anticholinergic effects. These findings highlight the potential for age-related differences in drug effects, suggesting the need for careful monitoring and dose adjustments when prescribing prochlorperazine to older adults. They also observed a trend towards prolonged reaction time in the elderly, raising concerns about potential cognitive effects.

Dr. Camel's Conclusion

This research, like a journey through a desert of age-related changes, highlights the importance of considering age-related factors when prescribing prochlorperazine to older adults. The authors' findings suggest that while the pharmacokinetics of intravenous prochlorperazine may be similar between age groups, oral bioavailability and drug effects may differ. This research underscores the need for careful monitoring and dose adjustments to optimize treatment outcomes and minimize potential adverse effects.
Date :
  1. Date Completed 1992-04-29
  2. Date Revised 2019-05-09
Further Info :

Pubmed ID

1553856

DOI: Digital Object Identifier

10.1093/ageing/21.1.27

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.